Major players in the cardiac assist devices and equipment market are Abbot Laboratories, Berlin Heart GmbH, Abiomed Inc. , Bivacor Pvt Ltd. , Calon Cardio - Technology Ltd. , Cardiobridge GmbH, Balton Sp.
New York, May 16, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cardiac Assist Devices And Equipment Global Market Report 2022" - https://www.reportlinker.com/p06277191/?utm_source=GNW Z O.O, Cardiac Assist Inc., Braile Biomedica Ltd., and circulate Inc. The global cardiac assist devices and equipment market is expected to grow from $1.85 billion in 2021 to $2.15 billion in 2022 at a compound annual growth rate (CAGR) of 15.7%. The market is expected to grow to $3.58 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. The cardiac assist devices and equipment market consist of sales of cardiac assist devices and equipment and related services. Cardiac assist devices and equipment are electromechanical devices for assisting cardiac circulation, which are used either to partially or to completely replace the function of a failing heart. The main types of cardiac assist devices and equipment are ventricular assist devices, intra-aortic balloon pumps, and the total artificial heart.Ventricular assist devices refer to the electromechanical device that is used for assisting in cardiac circulation. The various types of modalities are transcutaneous and implantable. These are used in hospital pharmacies, ambulatory surgical centers, and emergency services. North America was the largest region in cardiac assist devices and equipment market in 2021.Western Europe was the second-largest region in cardiac assist devices and equipment market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. A rise in the prevalence of cardiovascular diseases increases the demand for cardiac assist devices and equipment in developed and developing economies.The increasing need for diagnosis, monitoring, early-stage treatment, and prevention of these life-threatening diseases, increase the demand for cardiac assist devices. According to the American Heart Association, by 2035, 45.1% of the US population is projected to have some form of CVD. Total costs of CVD are expected to reach $1.1 trillion in 2035, with direct medical costs projected to reach $748.7 billion and indirect costs estimated to reach $368 billion. According to the World Heart Federation 2019, 17.9 million people die every year from CVD, including heart disease and stroke. Risks associated with the implantation of cardiac assist devices into the human body acts as a major restraint for the growth of this market.Risks associated with device implantation include respiratory failure, blood clot formation, occurrences of stroke, and the risk of device failure leading to a heart attack are some major reasons due to which people are hesitant to adopt cardiac assist devices, thus the demand from end-users of cardiac assist devices remains restrained, therefore limiting the growth prospects of the market. The infection rate of cardiac implantable electronic devices is 1.7% initially after implantation, whereas after 2years the infection rate is 9.5%, increasing the risk factor. The rising number of device replacements results in complex procedures, considerable risks with an increase in infection rates. Device miniaturization is becoming popular in the cardiac assist devices and equipment market.The concept of minimizing the size of the cardiac assist devices enhances device implantation, provides potentially shorter hospital stay through the use of less invasive surgery such as ’Thoracotomy’. Cardiac assist device miniaturization acts as a replacement to heart transplantation as destination therapy, due to lack of heart donors. For instance, Heartware Ltd. is increasingly investing in the Heartware’s device miniaturization program, aiming to reduce the weight, size, and energy consumption of the device. Furthermore, the United Kingdom National Health Service has invested in a Bridge to Transplant program (BTT) where the performance of two minimally invasive cardiac assist devices was compared, out of which the best one was found based on better clinical outcome and more cost-effectiveness due to its miniaturized design. In April 2019, the Food and Drug Administration (FDA), a federal agency of the US department of health and human services, a regulatory body, has sent a product recall notice to Thoratec Corporation, for its product Heartmate II, a left ventricular assist system, EU, due to adverse risks, blood pumping issues, use problems, power and battery problems identified. FDA has sent a notice for product recall as the product defect contributed to aortic insufficiency and potential pump obstruction in the patient which led to an emergency heart transplant. The countries covered in the cardiac assist devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, USA, and Australia. Read the full report: https://www.reportlinker.com/p06277191/?utm_source=GNW About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________
The markets may be in free fall, but a few biotechnology companies had an exceptionally good day. Siga’s stock is up more than 40%; Emergent Biosolutions’s gained nearly 12%, and Tonix Pharmaceuticals, 15%. A few cases of monkeypox have been registered in Europe and North America, far from West and Central Africa where outbreaks typically emerge.
Here's why they picked Exelixis (NASDAQ: EXEL), Moderna (NASDAQ: MRNA), and Vertex Pharmaceuticals (NASDAQ: VRTX). David Jagielski (Exelixis): If you're looking to hit a home run with an investment, it's important to look for a balance of a modest valuation and promising growth. One underrated stock that possesses all these features is cancer-fighting company Exelixis, which has a market cap of around $5.4 billion.
J.M. Smucker says the potentially contaminated items include jars of Jif Creamy and Jif Crunchy peanut butters as well as some products in squeeze pouches.
The U.S. Food and Drug Administration, along with Centers for Disease Control and Prevention, and others have been investigating a multistate outbreak of salmonella senftenberg infections and they are linked to a product so many of us enjoy daily.
Not to worry you, but you could be low in a mineral that you rarely think about.
Monkeypox cases in Spain have been linked to a superspreader event at an adult sauna in Madrid.
What is a normal, healthy resting heart rate, and what it means if your heart is beating slower or faster than it should.
Infections in UK more than double to 20
The go-ahead covers a chronic inflammatory disease for which the Food and Drug Administration has never before approved a treatment.
The biotech company announced on Thursday that the Food and Drug Administration placed a hold on its leukemia study.
J.M. Smucker Co. has recalled some Jif peanut butter products amid a salmonella outbreak that has resulted in illnesses in 12 states.
Monkeypox causes lesions that resemble pus-filled blisters, which eventually scab over. CDC/Getty ImagesOn May 18, 2022, Massachusetts health officials and the Centers for Disease Control and Prevention confirmed a single case of monkeypox in a patient who had recently traveled to Canada. Cases have also been reported in the United Kingdom and Europe. Monkeypox isn’t a new disease. The first confirmed human case was in 1970, when the virus was isolated from a child suspected of having smallpox i
This easy meal plan for diabetes will help you lower your blood pressure while keeping your blood sugars in check—all while eating deliciously.
On this week’s episode of why Black Twitter is losing their minds, folks have been in absolute shambles after Lori Harvey revealed her dietary habits. The 25 year old influencer recently shared on TikTok her very own “weight loss hack,” leaving many with raised eyebrows, strained necks, and in hand over hip formation. Harvey, who has been dating actor Michael B. Jordan for nearly two years, told her followers that she gained 15 pounds of “relationship weight” after the couple got together.
Marcia Herman-Giddens first realized something was changing in young girls in the late 1980s, while she was serving as director for the child abuse team at Duke University Medical Center in Durham, North Carolina. During evaluations of girls who had been abused, Herman-Giddens noticed that many of them had started developing breasts as young as 6 or 7. “That did not seem right,” said Herman-Giddens, who is now an adjunct professor at the University of North Carolina Gillings School of Global Pub
Experts urge researchers to be wary of red herrings, divorce politics, and embrace scientific thought
Cases of monkeypox, a rare viral infection found in west and central African countries, are being reported around the globe, with confirmed cases now in Canada.
The FDA says the J.M. Smucker Co. is recalling select Jif peanut butter products sold in the U.S. due to potential Salmonella contamination.
The baby formula shortage has led some anxious parents to seek out alternatives, like how to make homemade baby formula. Here's a doctor's advice.
Abortion providers in Oklahoma say they will no longer provide the service after the governor signs the latest anti-abortion measure heading to his desk. It's part of an aggressive push in Republican-led states to scale back abortion rights. (May 20)